D&D Pharmatech
↗Seongnam-si, South Korea
D&D Pharmatech is a clinical-stage global biotechnology company headquartered in South Korea, specializing in the development of disease-modifying therapeutics for metabolic, neurodegenerative, and fibrotic diseases. The company operates through a unique decentralized model, utilizing disease-specific subsidiaries such as Neuraly (neurodegeneration), Theraly (fibrosis), and Precision Molecular (imaging) to translate academic research from institutions like Johns Hopkins University into clinical assets.
The company's lead program, DD01, is a long-acting dual GLP-1/glucagon receptor agonist being developed for metabolic dysfunction-associated steatohepatitis (MASH). D&D Pharmatech is also advancing a robust pipeline of oral peptide therapeutics leveraging its proprietary ORALINK platform, which aims to convert injectable biologics into convenient oral formulations, particularly in the highly competitive GLP-1 market.
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:-
Industry:Biotechnology
Sub-Industry:Metabolic and CNS Therapeutics
SIZE & FINANCIALS
Employees:51-200
Revenue:Pre-revenue
Founded:2014
Ownership:public
Status:operating
FUNDING
Stage:Public
Total Raised:$190M
Investors:Smilegate Investment, InterVest, Quantum Frontier, DS Asset Management, KTB Network
STOCK
Exchange:KOSDAQ
Ticker:227110
Market Cap:$450M
PIPELINE
Stage:Phase 2
Lead Drug Stage:Phase 2
Modalities:Peptides, Small molecule, Dual Agonists, Oral Biologics
Active Trials:4
Trial Phases:Phase 1: 2 | Phase 2: 2
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Subsidiaries:Neuraly, Inc., Theraly, Inc., Precision Molecular, Inc., Valted Seq, Inc., P4Microbiome
Key Partnerships:Metsera (Licensing deal for oral GLP-1 portfolio), Johns Hopkins University (Scientific collaboration), Takeda (Historical collaboration on lurasidone)
COMPETITION
Position:Emerging
Competitors:Novo Nordisk, Eli Lilly, Viking Therapeutics, Akero Therapeutics, 89bio
LEADERSHIP
Key Executives:
Seulki Lee - CEO & Founder
Viktor Roschke - CSO
Scientific Founders:Ted Dawson, Valina Dawson
Board Members:Seulki Lee, Sang-Yoon Lee, Young-Ho Kim
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with D&D Pharmatech. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.